Center for Pharmaceutical Policy and Prescribing
@pittcp3.bsky.social
Center for Pharmaceutical Policy and Prescribing at the University of Pittsburgh. Our research helps improve quality, safety, & efficiency of medication use.
Pinned
👋Greetings to our new followers! CP3 conducts research to inform the regulation, coverage, & equitable access of #pharmaceuticals & improving patient & prescriber decision-making on #prescriptiondrugs.
Get to know our work & join our mailing list: www.cp3.pitt.edu
#healthpolicy #rxsky #medsky
Get to know our work & join our mailing list: www.cp3.pitt.edu
#healthpolicy #rxsky #medsky
New national study shows alcohol-related hospitalizations stayed stable from 2016–2022, but mortality, length of stay, & costs rose. Findings highlight the need for prevention & earlier AUD treatment to improve outcomes & reduce spending.
@timandersonmd.bsky.social
jamanetwork.com/journals/jam...
@timandersonmd.bsky.social
jamanetwork.com/journals/jam...
January 7, 2026 at 6:14 PM
New national study shows alcohol-related hospitalizations stayed stable from 2016–2022, but mortality, length of stay, & costs rose. Findings highlight the need for prevention & earlier AUD treatment to improve outcomes & reduce spending.
@timandersonmd.bsky.social
jamanetwork.com/journals/jam...
@timandersonmd.bsky.social
jamanetwork.com/journals/jam...
Many older adults are stopping their #GLP-1 medications. @nytimes.com spoke with experts, including CP3's @timandersonmd.bsky.social to learn more.
@pittdeptofmed.bsky.social @pittgim.bsky.social
www.nytimes.com/2025/12/21/h...
@pittdeptofmed.bsky.social @pittgim.bsky.social
www.nytimes.com/2025/12/21/h...
Older Americans Quit Weight-Loss Drugs in Droves
www.nytimes.com
January 5, 2026 at 4:04 PM
Many older adults are stopping their #GLP-1 medications. @nytimes.com spoke with experts, including CP3's @timandersonmd.bsky.social to learn more.
@pittdeptofmed.bsky.social @pittgim.bsky.social
www.nytimes.com/2025/12/21/h...
@pittdeptofmed.bsky.social @pittgim.bsky.social
www.nytimes.com/2025/12/21/h...
More than 1 in 10 older adults in Medicare Part D Medication Therapy Management use multiple CNS meds, increasing fall risk, yet only ~1/3 get a comprehensive med review. Better engagement needed to reduce risk.
@timandersonmd.bsky.social
www.jmcp.org/doi/10.18553...
@timandersonmd.bsky.social
www.jmcp.org/doi/10.18553...
January 5, 2026 at 3:04 PM
More than 1 in 10 older adults in Medicare Part D Medication Therapy Management use multiple CNS meds, increasing fall risk, yet only ~1/3 get a comprehensive med review. Better engagement needed to reduce risk.
@timandersonmd.bsky.social
www.jmcp.org/doi/10.18553...
@timandersonmd.bsky.social
www.jmcp.org/doi/10.18553...
Congrats to Yujin Seo (CMU), working with CP3’s Dr. Katie Suda, on presenting at the IQVIA Institute Research Forum. Her poster shows drug shortages hit older adults hardest, with faster fill declines among Medicare/Medicaid patients and those linked to rural or lower-income prescribers.
December 19, 2025 at 3:32 PM
Congrats to Yujin Seo (CMU), working with CP3’s Dr. Katie Suda, on presenting at the IQVIA Institute Research Forum. Her poster shows drug shortages hit older adults hardest, with faster fill declines among Medicare/Medicaid patients and those linked to rural or lower-income prescribers.
New study co-authored by CP3’s @timandersonmd.bsky.social shows limited lecanemab uptake in the VHA and that nearly 30% of patients had ARIA or stroke within 7 months of starting treatment, highlighting the need for careful long-term safety and effectiveness monitoring.
www.mdpi.com/2077-0383/14...
www.mdpi.com/2077-0383/14...
December 18, 2025 at 2:57 PM
New study co-authored by CP3’s @timandersonmd.bsky.social shows limited lecanemab uptake in the VHA and that nearly 30% of patients had ARIA or stroke within 7 months of starting treatment, highlighting the need for careful long-term safety and effectiveness monitoring.
www.mdpi.com/2077-0383/14...
www.mdpi.com/2077-0383/14...
Welcome to CP3! Juan M. Hincapie-Castillo (@drjuanhc.com) will join Pitt’s School of Pharmacy as Associate Professor (pending) in Jan 2026 & as a CP3 faculty affiliate. A longtime collaborator & 2024 Pharmacoequity panelist, his work focuses on legal epidemiology & evidence-based policymaking.
December 17, 2025 at 6:04 PM
Welcome to CP3! Juan M. Hincapie-Castillo (@drjuanhc.com) will join Pitt’s School of Pharmacy as Associate Professor (pending) in Jan 2026 & as a CP3 faculty affiliate. A longtime collaborator & 2024 Pharmacoequity panelist, his work focuses on legal epidemiology & evidence-based policymaking.
🆕study in @addictionjournal.bsky.social shows how lookback window & washout choices in MOUD research affect sample size, demographics, & tx start misclassification. It offers practical guidance to improve comparative studies in #opioid use disorder research.
onlinelibrary.wiley.com/doi/10.1111/...
onlinelibrary.wiley.com/doi/10.1111/...
December 17, 2025 at 5:36 PM
🆕study in @addictionjournal.bsky.social shows how lookback window & washout choices in MOUD research affect sample size, demographics, & tx start misclassification. It offers practical guidance to improve comparative studies in #opioid use disorder research.
onlinelibrary.wiley.com/doi/10.1111/...
onlinelibrary.wiley.com/doi/10.1111/...
CP3 Associate Director Dr. Katie Suda was interviewed for Dr. Bicuspid on the risks of prescribing #opioids to pediatric patients.
Read the interview and more on Dr. Suda's study here: www.drbicuspid.com/dental-speci...
Read the interview and more on Dr. Suda's study here: www.drbicuspid.com/dental-speci...
The risks when dentists give pediatrics opioids
About 1 in 10 pediatric dental visits involving opioids were linked to overdose or persistent use.
www.drbicuspid.com
December 16, 2025 at 8:15 PM
CP3 Associate Director Dr. Katie Suda was interviewed for Dr. Bicuspid on the risks of prescribing #opioids to pediatric patients.
Read the interview and more on Dr. Suda's study here: www.drbicuspid.com/dental-speci...
Read the interview and more on Dr. Suda's study here: www.drbicuspid.com/dental-speci...
New study finds telehealth and a gradual return to in-person visits helped restore outpatient care for patients with atrial fibrillation after the pandemic. But recovery was uneven, with notable differences by patients’ pre-pandemic outpatient use.
link.springer.com/article/10.1...
link.springer.com/article/10.1...
December 16, 2025 at 3:47 PM
New study finds telehealth and a gradual return to in-person visits helped restore outpatient care for patients with atrial fibrillation after the pandemic. But recovery was uneven, with notable differences by patients’ pre-pandemic outpatient use.
link.springer.com/article/10.1...
link.springer.com/article/10.1...
🆕study finds global #drugshortages persist & disproportionately affect countries with lower GDP per capita. Essential medicines are unevenly impacted worldwide, highlighting the need for policy solutions beyond pricing to address shortages & global inequities. gh.bmj.com/content/10/1...
December 15, 2025 at 1:53 PM
🆕study finds global #drugshortages persist & disproportionately affect countries with lower GDP per capita. Essential medicines are unevenly impacted worldwide, highlighting the need for policy solutions beyond pricing to address shortages & global inequities. gh.bmj.com/content/10/1...
We had a fun watch party for our friend and colleague Dr. Lu Tang's Senior Vice Chancellor’s Research Seminar! We've been lucky to work with Dr. Tang on our risk prediction projects and enjoyed his amazing talk on innovative analytic methods for precision health care!
@pittmed.bsky.social
@pittmed.bsky.social
December 12, 2025 at 6:42 PM
We had a fun watch party for our friend and colleague Dr. Lu Tang's Senior Vice Chancellor’s Research Seminar! We've been lucky to work with Dr. Tang on our risk prediction projects and enjoyed his amazing talk on innovative analytic methods for precision health care!
@pittmed.bsky.social
@pittmed.bsky.social
New study led by CP3’s Dr. Jenny Lo-Ciganic presents a dynamic risk model that efficiently identifies older adults at high fall-related injury risk—offering a tool to inform clinical decisions and better target prevention resources.
accpjournals.onlinelibrary.wiley.com/doi/10.1002/...
accpjournals.onlinelibrary.wiley.com/doi/10.1002/...
December 12, 2025 at 2:47 PM
New study led by CP3’s Dr. Jenny Lo-Ciganic presents a dynamic risk model that efficiently identifies older adults at high fall-related injury risk—offering a tool to inform clinical decisions and better target prevention resources.
accpjournals.onlinelibrary.wiley.com/doi/10.1002/...
accpjournals.onlinelibrary.wiley.com/doi/10.1002/...
🆕 @jamahealthforum.com study of 13.8M ARB users found adherence didn’t change 18 months after the recalls, many switched to alternatives within 90 days, & switching didn’t raise insurer or out-of-pocket drug costs.
jamanetwork.com/journals/jam...
jamanetwork.com/journals/jam...
December 11, 2025 at 7:24 PM
🆕 @jamahealthforum.com study of 13.8M ARB users found adherence didn’t change 18 months after the recalls, many switched to alternatives within 90 days, & switching didn’t raise insurer or out-of-pocket drug costs.
jamanetwork.com/journals/jam...
jamanetwork.com/journals/jam...
Using real-world data, our colleagues (including CP3's Dr. Jenny Lo-Ciganic) found for PPH, the top-ranked risk factor was placenta previa or accreta, the top-ranked comorbidity was primary cesarean delivery, & the commonest cause was uterine atony.
Read more: www.researchsquare.com/article/rs-7...
Read more: www.researchsquare.com/article/rs-7...
December 10, 2025 at 3:16 PM
Using real-world data, our colleagues (including CP3's Dr. Jenny Lo-Ciganic) found for PPH, the top-ranked risk factor was placenta previa or accreta, the top-ranked comorbidity was primary cesarean delivery, & the commonest cause was uterine atony.
Read more: www.researchsquare.com/article/rs-7...
Read more: www.researchsquare.com/article/rs-7...
CP3's Dr. Jenny Lo-Ciganic was part of a team that examined associations between trajectories of #buprenorphine use & time to adverse outcomes among youth. Bottom line: Medication adherence may prevent overdose, ED use, and hospitalization.
Read more: publications.aap.org/pediatrics/a...
Read more: publications.aap.org/pediatrics/a...
December 9, 2025 at 3:03 PM
CP3's Dr. Jenny Lo-Ciganic was part of a team that examined associations between trajectories of #buprenorphine use & time to adverse outcomes among youth. Bottom line: Medication adherence may prevent overdose, ED use, and hospitalization.
Read more: publications.aap.org/pediatrics/a...
Read more: publications.aap.org/pediatrics/a...
CP3's @timandersonmd.bsky.social was lead author on this paper describing study results including that most hospitalized older adults discharged w/cardiometabolic 💊 changes experienced 💊 errors or gaps in discharge planning.
Read more @journalgim.bsky.social:
link.springer.com/article/10.1...
Read more @journalgim.bsky.social:
link.springer.com/article/10.1...
December 8, 2025 at 6:55 PM
CP3's @timandersonmd.bsky.social was lead author on this paper describing study results including that most hospitalized older adults discharged w/cardiometabolic 💊 changes experienced 💊 errors or gaps in discharge planning.
Read more @journalgim.bsky.social:
link.springer.com/article/10.1...
Read more @journalgim.bsky.social:
link.springer.com/article/10.1...
Growing use of antiobesity medications means that clinicians must be aware of risks and benefits of starting & stopping them. In @jamainternalmed.com, Dr. Elizabeth Oczypok & CP3's @timandersonmd.bsky.social share important lessons gleaned from research settings.
jamanetwork.com/journals/jam...
jamanetwork.com/journals/jam...
December 5, 2025 at 3:46 PM
Growing use of antiobesity medications means that clinicians must be aware of risks and benefits of starting & stopping them. In @jamainternalmed.com, Dr. Elizabeth Oczypok & CP3's @timandersonmd.bsky.social share important lessons gleaned from research settings.
jamanetwork.com/journals/jam...
jamanetwork.com/journals/jam...
The DEMONSTRATE trial will assess a #MachineLearning based clinical decision support tool to reduce #opioid harm in elevated risk patients. This paper describes the protocol that will provide real-world evidence for the tool.
Read more: www.mdpi.com/2077-0383/14...
Read more: www.mdpi.com/2077-0383/14...
December 4, 2025 at 3:11 PM
The DEMONSTRATE trial will assess a #MachineLearning based clinical decision support tool to reduce #opioid harm in elevated risk patients. This paper describes the protocol that will provide real-world evidence for the tool.
Read more: www.mdpi.com/2077-0383/14...
Read more: www.mdpi.com/2077-0383/14...
CP3's Dr. Luke Berenbrok spoke with @newsweek.com about ways #Medicare users can ensure they are using all of their benefits, especially those for OTC items. He suggests talking with community pharmacists for help with understanding what products are covered.
www.newsweek.com/medicare-use...
www.newsweek.com/medicare-use...
Medicare users are leaving billions of dollars of benefits unused
Millions of Americans using Medicare Advantage may be leaving billions of dollars worth of benefits unused.
www.newsweek.com
December 3, 2025 at 7:47 PM
CP3's Dr. Luke Berenbrok spoke with @newsweek.com about ways #Medicare users can ensure they are using all of their benefits, especially those for OTC items. He suggests talking with community pharmacists for help with understanding what products are covered.
www.newsweek.com/medicare-use...
www.newsweek.com/medicare-use...
CP3’s Dr. Julie Donohue and colleagues urge continued investment in strong, objective health policy research—calling for innovative methods and data sources to guide the future of health care and strengthen the evidence base.
Read more @jamahealthforum.com:
jamanetwork.com/journals/jam...
Read more @jamahealthforum.com:
jamanetwork.com/journals/jam...
November 25, 2025 at 2:32 PM
CP3’s Dr. Julie Donohue and colleagues urge continued investment in strong, objective health policy research—calling for innovative methods and data sources to guide the future of health care and strengthen the evidence base.
Read more @jamahealthforum.com:
jamanetwork.com/journals/jam...
Read more @jamahealthforum.com:
jamanetwork.com/journals/jam...
🆕 @jamainternalmed.com, CP3's @bryantshuey.bsky.social, @timandersonmd.bsky.social, & Dr. Ted Park break down new ASAM #benzodiazepine tapering guidelines, highlighting how to support safer #deprescribing, especially for high-risk patients.
jamanetwork.com/journals/jam...
@pittgim.bsky.social
jamanetwork.com/journals/jam...
@pittgim.bsky.social
November 24, 2025 at 5:32 PM
🆕 @jamainternalmed.com, CP3's @bryantshuey.bsky.social, @timandersonmd.bsky.social, & Dr. Ted Park break down new ASAM #benzodiazepine tapering guidelines, highlighting how to support safer #deprescribing, especially for high-risk patients.
jamanetwork.com/journals/jam...
@pittgim.bsky.social
jamanetwork.com/journals/jam...
@pittgim.bsky.social
Have you heard of Pitt's Healthy Home Lab? It's one of the innovations led by our parent org, Pitt's Health Policy Institute. In @publicsource.org, read about it and other solutions to help older adults:
www.publicsource.org/pennsylvania...
www.publicsource.org/pennsylvania...
From singing robots to living laboratories, care leaders seek solutions to aging Pittsburgh’s needs
Aging populations in Western Pennsylvania and assisted living staffing shortages prompt tech innovations and workforce development efforts.
www.publicsource.org
November 13, 2025 at 7:31 PM
Have you heard of Pitt's Healthy Home Lab? It's one of the innovations led by our parent org, Pitt's Health Policy Institute. In @publicsource.org, read about it and other solutions to help older adults:
www.publicsource.org/pennsylvania...
www.publicsource.org/pennsylvania...
ICYMI: CP3's @bryantshuey.bsky.social was recently chosen as a @nam.edu State Health Policy Fellow. Dr. Shuey will use his expertise in addiction issues to advise the PA Department of Health's Office of Drug Surveillance and Misuse Prevention.
www.medschool.pitt.edu/news/bryant-...
www.medschool.pitt.edu/news/bryant-...
Bryant Shuey Chosen for State Health Policy Fellowship | School of Medicine | University of Pittsburgh
Bryant Shuey, assistant professor of medicine, University of Pittsburgh, is one of five fellows selected for the National Academy of Medicine (NAM)’s State Health Policy Fellowship (SHPF) program anno...
www.medschool.pitt.edu
November 10, 2025 at 2:14 PM
ICYMI: CP3's @bryantshuey.bsky.social was recently chosen as a @nam.edu State Health Policy Fellow. Dr. Shuey will use his expertise in addiction issues to advise the PA Department of Health's Office of Drug Surveillance and Misuse Prevention.
www.medschool.pitt.edu/news/bryant-...
www.medschool.pitt.edu/news/bryant-...
🆕editorial co-authored by CP3’s Dr. Julie Donohue argues that as health policy enters a turbulent era, research must focus not only on access, cost, & quality, but also on system innovations, SDoH, & emerging tools like AI.
@jamahealthforum.com:
jamanetwork.com/journals/jam...
@jamahealthforum.com:
jamanetwork.com/journals/jam...
November 5, 2025 at 2:09 PM
🆕editorial co-authored by CP3’s Dr. Julie Donohue argues that as health policy enters a turbulent era, research must focus not only on access, cost, & quality, but also on system innovations, SDoH, & emerging tools like AI.
@jamahealthforum.com:
jamanetwork.com/journals/jam...
@jamahealthforum.com:
jamanetwork.com/journals/jam...
🆕study co-authored by CP3’s Dr. Bernie Good finds that a targeted pharmacy-care-management service ⬆️💊 adherence & ⬇️resource use among Medicare Advantage beneficiaries—supporting broader use of pharmacist-led models in managing cardiometabolic conditions.
Read more: www.jmcp.org/doi/10.18553...
Read more: www.jmcp.org/doi/10.18553...
November 3, 2025 at 3:57 PM
🆕study co-authored by CP3’s Dr. Bernie Good finds that a targeted pharmacy-care-management service ⬆️💊 adherence & ⬇️resource use among Medicare Advantage beneficiaries—supporting broader use of pharmacist-led models in managing cardiometabolic conditions.
Read more: www.jmcp.org/doi/10.18553...
Read more: www.jmcp.org/doi/10.18553...